Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Data Vision Co's ROE % for the quarter that ended in Dec. 2025 was 19.73%. Medical Data Vision Co's PB Ratio for the quarter that ended in Dec. 2025 was 20.73.
Medical Data Vision Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 0.95%.
Medical Data Vision Co ROE % Adjusted to Book Value Related Terms
Medical Data Vision Co ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Medical Data Vision Co's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Data Vision Co ROE % Adjusted to Book Value Chart
TSE:3902 vs VEEV, TEM, BTSG: ROE % Adjusted to Book Value Comparison
For the Health Information Services subindustry, Medical Data Vision Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Data Vision Co ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Medical Data Vision Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 0.95% mean?
Medical Data Vision Co (TSE:3902) has a ROE % Adjusted to Book Value of 0.95% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medical Data Vision Co and its competitors.
Is Medical Data Vision Co's ROE % Adjusted to Book Value too high?
Medical Data Vision Co's current ROE % Adjusted to Book Value is 0.95%. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's ROE % Adjusted to Book Value compare to VEEV and TEM?
Medical Data Vision Co's ROE % Adjusted to Book Value of 0.95% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medical Data Vision Co and its competitors. Medical Data Vision Co's current ROE % Adjusted to Book Value is 0.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current ROE % Adjusted to Book Value of 0.95%. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current ROE % Adjusted to Book Value is 0.95%. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current ROE % Adjusted to Book Value is 0.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
ROE % Adjusted to Book Value: 0.95%
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
